Vanda Pharmaceuticals rejects Future Pak’s acquisition offer

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) has officially declined the latest acquisition proposal from Future Pak, LLC (FP), citing substantial undervaluation and significant risk. The offer, ... Read More